Market By Product, Application, End-user And Geography | Forecast 2019-2027
Triton's report on the European western blotting market has determined it to flourish at 4.60% of CAGR during the forecast years between 2019 and 2027.
The countries that have been analyzed in Europe’s western blotting market are:
• The United Kingdom
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe
Report scope can be customized per your requirements. Request For Customization
The presence of a well-established healthcare system and biotechnology industry mainly drive the Europe western blotting market. The market for western blotting in the United Kingdom is growing due to government reforms and the presence of favorable reimbursement policies. The healthcare sector in the UK is expected to increase by 2% annually until 2018. Moreover, the government of the UK is committed to its NHS Five-Year Forward View (5YFV), wherein, new healthcare models (therapeutics and diagnostics) would be implemented during the period 2015-2020. With a consistent investment record in R&D, the country is bound to gain the upper hand over other EU nation-states in the healthcare sector. The research & development in healthcare stood at 0.3% of the GDP, i.e. $2600 million, and is anticipated to increase by $620 million in 2020.
Moreover, the presence of the British HIV Association (BHIVA) and opt-in/opt-out HIV testing is increasing the usage of western blotting, thereby increasing the market growth in this region. The country’s top market players are undertaking strategic steps such as new product developments, mergers & acquisitions, distribution agreements and partnership agreements in order to increase their market share. All these factors are contributing to the growth of the western blotting market in the region. The western blotting market in Italy is rapidly growing as the Lyme disease is known to be an endemic disease in the country. The increasing awareness of the disease in the country is helping the market to grow. However, the increasing awareness in Italy regarding HIV AIDS has reduced the number of HIV cases in the region hampering the growth of the market in the coming years. Travel companies in Italy are spreading the awareness of Lyme disease, further strengthening the western blotting market in the country.
Merck KGaA is a multinational science & technology company, founded in Germany. The mainly works in three domains: Healthcare, Performance Materials and Life Sciences. The Merck Group reported revenues of (Euro) EUR 15, 327 million for FY2017, with an increase of 2% over FY2016. The company’s strength lies in its capability to conduct its R&D activities worldwide. The company has a strong geographic hold when compared to the other companies; the Merck Group has its presence in 66 countries in the world. The increasing number of strategic initiatives by the company to drive its business opportunities will increase the demand of the company.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
EUROPE WESTERN BLOTTING MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. GROWING NUMBER OF APPLICATIONS FOR WESTERN
BLOTTING
2.2.2. GROWING ACCEPTANCE OF DIGITAL WESTERN
BLOTTING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWING OCCURRENCE OF HIV AND LYME DISEASE
2.6.2. HIGH DEMAND FOR PROTEOMICS
2.6.3. RISE IN APPLICATIONS FOR WESTERN BLOTTING
2.7. MARKET RESTRAINTS
2.7.1. ADVANCEMENTS IN SUBSTITUTE TECHNOLOGIES
2.8. MARKET OPPORTUNITIES
2.8.1. INDUSTRIALIZATION OF WESTERN BLOT INSTRUMENTS
2.9. MARKET CHALLENGES
2.9.1. INFLATED COST OF ANTIBODIES
2.9.2. GROWING RESEARCH INITIATIVES AND R&D
EXPENDITURE BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
3.
WESTERN BLOTTING MARKET OUTLOOK - BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS AND BUFFERS
3.1.2. KITS
3.1.3. OTHER CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING SYSTEMS
3.2.2.1. DRY BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY BLOTTING SYSTEMS
3.2.2.3. WET BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT IMAGERS
3.2.3.2. FLUORESCENT IMAGERS
3.2.3.3. OTHER IMAGERS
4.
WESTERN BLOTTING MARKET OUTLOOK - BY APPLICATION
4.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
4.2. DISEASE DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER APPLICATIONS
5.
WESTERN BLOTTING MARKET OUTLOOK - BY END-USER
5.1. RESEARCH INSTITUTES
5.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC CENTERS
5.4. OTHER END-USERS
6.
WESTERN BLOTTING MARKET - REGIONAL OUTLOOK
6.1. EUROPE
6.1.1. UNITED KINGDOM
6.1.2. GERMANY
6.1.3. FRANCE
6.1.4. SPAIN
6.1.5. ITALY
6.1.6. RUSSIA
6.1.7. REST OF EUROPE
7.
COMPETITIVE LANDSCAPE
7.1. F. HOFFMAN LA-ROCHE LTD.
7.2. MERCK KGAA
7.3. THERMO FISHER SCIENTIFIC, INC.
7.4. BIO-RAD TECHNOLOGIES INC.
7.5. BIO-TECHNE CORPORATION
7.6. CELL SIGNALING TECHNOLOGY INC.
7.7. GE HEALTHCARE
7.8. LI-COR INC.
7.9. ADVANSTA
7.10. AZURE BIOSYSTEMS INC.
7.11. PERKINELEMER INC.
7.12. ROCHE DIAGNOSTICS INTERNATIONAL INC.
7.13. ROCHE DIAGNOSTICS
7.14. LUMIGEN INC.
7.15. ROCKLAND IMMUNOCHEMICALS INC.
8.
METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1. EUROPE WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $
MILLION)
TABLE 2. MARKET ATTRACTIVENESS INDEX
TABLE 3. VENDOR SCORECARD
TABLE 4. EUROPE WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $
MILLION)
TABLE 5. EUROPE WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2027 (IN $
MILLION)
TABLE 6. EUROPE WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2027 (IN $
MILLION)
TABLE 7. EUROPE WESTERN BLOTTING MARKET, BY END-USER, 2019-2027 (IN $
MILLION)
FIGURE 1. PORTER’S FIVE FORCE ANALYSIS
FIGURE 2. EUROPE WESTERN BLOTTING MARKET, BY CONSUMABLES, 2019-2027 (IN
$ MILLION)
FIGURE 3. EUROPE WESTERN BLOTTING MARKET, BY REAGENTS AND BUFFERS,
2019-2027 (IN $ MILLION)
FIGURE 4. EUROPE WESTERN BLOTTING MARKET, BY KITS, 2019-2027 (IN $
MILLION)
FIGURE 5. EUROPE WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES,
2019-2027 (IN $ MILLION)
FIGURE 6. EUROPE WESTERN BLOTTING MARKET, BY INSTRUMENTS, 2019-2027 (IN
$ MILLION)
FIGURE 7. EUROPE WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS
INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8. EUROPE WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2019-2027
(IN $ MILLION)
FIGURE 9. EUROPE WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS,
2019-2027 (IN $ MILLION)
FIGURE 10. EUROPE WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS,
2019-2027 (IN $ MILLION)
FIGURE 11. EUROPE WESTERN BLOTTING MARKET, BY WET BLOTTING SYSTEMS,
2019-2027 (IN $ MILLION)
FIGURE 12. EUROPE WESTERN BLOTTING MARKET, BY IMAGERS, 2019-2027 (IN $
MILLION)
FIGURE 13. EUROPE WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS,
2019-2027 (IN $ MILLION)
FIGURE 14. EUROPE WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS,
2019-2027 (IN $ MILLION)
FIGURE 15. EUROPE WESTERN BLOTTING MARKET, BY OTHER IMAGERS, 2019-2027
(IN $ MILLION)
FIGURE 16. EUROPE WESTERN BLOTTING MARKET, BY BIOMEDICAL &
BIOCHEMICAL RESEARCH, 2019-2027 (IN $ MILLION)
FIGURE 17. EUROPE WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS,
2019-2027 (IN $ MILLION)
FIGURE 18. EUROPE WESTERN BLOTTING MARKET, BY AGRICULTURE, 2019-2027 (IN
$ MILLION)
FIGURE 19. EUROPE WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS,
2019-2027 (IN $ MILLION)
FIGURE 20. EUROPE WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES,
2019-2027 (IN $ MILLION)
FIGURE 21. EUROPE WESTERN BLOTTING MARKET, BY PHARMACEUTICAL &
BIOTECHNOLOGY COMPANIES, 2019-2027 (IN $ MILLION)
FIGURE 22. EUROPE WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS,
2019-2027 (IN $ MILLION)
FIGURE 23. EUROPE WESTERN BLOTTING MARKET, BY OTHER END-USERS, 2019-2027
(IN $ MILLION)
FIGURE 24. EUROPE WESTERN BLOTTING MARKET, REGIONAL OUTLOOK, 2018 &
2027 (IN %)
FIGURE 25. UNITED KINGDOM WESTERN BLOTTING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 26. GERMANY WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 27. FRANCE WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 28. SPAIN WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 29. ITALY WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 30. RUSSIA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 31. REST OF EUROPE WESTERN BLOTTING MARKET, 2019-2027 (IN $
MILLION)